Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research
In this article, a hybrid retina construct was created via three-dimensional (3D) bioprinting technology. The construct was composed of a PCL ultrathin membrane, ARPE-19 cell monolayer and Y79 cell-laden alginate/pluronic bioink. 3D bioprinting technology was applied herein to deliver the ARPE-19 ce...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/85384 http://hdl.handle.net/10220/45150 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-85384 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-853842023-03-04T17:12:00Z Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research Shi, Pujiang Yeong, Wai Yee Laude, Augustinus Tan, Edgar Yong Sheng School of Mechanical and Aerospace Engineering Singapore Centre for 3D Printing Retina Bioprinting In this article, a hybrid retina construct was created via three-dimensional (3D) bioprinting technology. The construct was composed of a PCL ultrathin membrane, ARPE-19 cell monolayer and Y79 cell-laden alginate/pluronic bioink. 3D bioprinting technology was applied herein to deliver the ARPE-19 cells and Y79 cell-laden bioink to ensure homogeneous ARPE-19 cell seeding; subsequently, two distinctive Y79 cell-seeding patterns were bioprinted on top of the ARPE-19 cell monolayer. The bioprinted ARPE-19 cells were evaluated by prestoblue assay, F-actin, and hematoxylin/eosin (HE) staining, and then the cells were observed under laser scanning and invert microscopy for 14 days. The Y79 cells in alginate/pluronic bioink after bioprinting had been closely monitored for 7 days. Live/dead assay and scanning electrical microscopy (SEM) were employed to investigate Y79 cell viability and morphology. Both the ARPE-19 and Y79 cells were in excellent condition, and the successfully bioprinted retina model could be utilized in drug delivery, disease mechanism and treatment method discoveries. Published version 2018-07-20T02:47:54Z 2019-12-06T16:02:50Z 2018-07-20T02:47:54Z 2019-12-06T16:02:50Z 2017 Journal Article Shi, P., Tan, E. Y. S., Yeong, W. Y., & Laude, A. (2017). Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research. International Journal of Bioprinting, 3(2), 138-146. https://hdl.handle.net/10356/85384 http://hdl.handle.net/10220/45150 10.18063/IJB.2017.02.008 en International Journal of Bioprinting © 2017 The Author(s) (International Journal of Bioprinting) (published by Whioce Publishing Pte Ltd). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 9 p. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Retina Bioprinting |
spellingShingle |
Retina Bioprinting Shi, Pujiang Yeong, Wai Yee Laude, Augustinus Tan, Edgar Yong Sheng Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research |
description |
In this article, a hybrid retina construct was created via three-dimensional (3D) bioprinting technology. The construct was composed of a PCL ultrathin membrane, ARPE-19 cell monolayer and Y79 cell-laden alginate/pluronic bioink. 3D bioprinting technology was applied herein to deliver the ARPE-19 cells and Y79 cell-laden bioink to ensure homogeneous ARPE-19 cell seeding; subsequently, two distinctive Y79 cell-seeding patterns were bioprinted on top of the ARPE-19 cell monolayer. The bioprinted ARPE-19 cells were evaluated by prestoblue assay, F-actin, and hematoxylin/eosin (HE) staining, and then the cells were observed under laser scanning and invert microscopy for 14 days. The Y79 cells in alginate/pluronic bioink after bioprinting had been closely monitored for 7 days. Live/dead assay and scanning electrical microscopy (SEM) were employed to investigate Y79 cell viability and morphology. Both the ARPE-19 and Y79 cells were in excellent condition, and the successfully bioprinted retina model could be utilized in drug delivery, disease mechanism and treatment method discoveries. |
author2 |
School of Mechanical and Aerospace Engineering |
author_facet |
School of Mechanical and Aerospace Engineering Shi, Pujiang Yeong, Wai Yee Laude, Augustinus Tan, Edgar Yong Sheng |
format |
Article |
author |
Shi, Pujiang Yeong, Wai Yee Laude, Augustinus Tan, Edgar Yong Sheng |
author_sort |
Shi, Pujiang |
title |
Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research |
title_short |
Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research |
title_full |
Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research |
title_fullStr |
Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research |
title_full_unstemmed |
Hybrid three-dimensional (3D) bioprinting of retina equivalent for ocular research |
title_sort |
hybrid three-dimensional (3d) bioprinting of retina equivalent for ocular research |
publishDate |
2018 |
url |
https://hdl.handle.net/10356/85384 http://hdl.handle.net/10220/45150 |
_version_ |
1759854343341735936 |